Alzheimers Drug Discovery Foundation

The Alzheimer’s Drug Discovery Foundation (ADDF) is a non-profit organization based in New York, New York. Founded in 1998, the ADDF is dedicated to accelerating the development of drugs to prevent and treat Alzheimer's disease and related dementias. The organization employs 30 people. The ADDF supports new drug discovery programs and clinical trials for Alzheimer's disease worldwide. Their expert neuroscientists identify promising research initiatives and ensure a diverse and robust pipeline of treatments. A pioneer in venture philanthropy, the ADDF focuses solely on funding Alzheimer's drug discovery, setting it apart from other charities. Since its inception, the organization has awarded over $100 million to fund more than 550 Alzheimer's drug discovery programs and clinical trials in 18 countries. Notably, 20% of all treatments for Alzheimer's currently in clinical trials have received support from the ADDF. Visit alzdiscovery.org to learn more about the Alzheimer’s Drug Discovery Foundation.